DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Biosensors Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering.
The global biosensors market accounted for revenues of $14,169.5 million in 2015, and it is expected to grow at a CAGR of 9.8% during the forecast period. Based on technology, the electrochemical segment dominates the biosensors market and is expected grow at a CAGR of 9.8% globally, during the forecast period. Based on application, the medical testing segment dominates the global biosensors market.
Biosensors are devices that use biological components to detect, analyses, and transmit information observing a physiological process or change. A variety of substances such as nucleic acid, protein including enzymes and antibodies, and complex materials are used as a bio-element in a biosensor. These bio-elements interact with analyte and further convert biological response into an electrical response. Electrochemical biosensors are analytical devices used to provide analytical information by biological sample, such as tissues, enzymes and whole cell, to an electrical signal. It is cost effective, user friendly, simple, disposable and convenient to use.
Some of the key companies operating in the global biosensors market include Siemens AG, LifeSensors, Inc., Nova Biomedical Corporation, Abbott Laboratories, Inc., Johnson and Johnson, Medtronic, PLC, I-SENS, Inc., F. Hoffmann La Roche, TaiDoc Technology Corporation, and ACON Laboratories.
Key Topics Covered:
1. Research Scope And Methodology
4.Global Biosensors Market Size And Forecast (2012-2022)
5.Global Biosensors Market, By Technology
6.Global Biosensors Market, By Application
7.Global Biosensors Market, By End User
8.Global Biosensors Market, By Geography
9.Competitive Positioning Analysis
10.Company Profiles And Strategic Developments
For more information about this report visit http://www.researchandmarkets.com/research/d53gdg/global_biosensors